Recently FDA approved Comaneci device aids in treating wide-neck aneurysms
Worcester, Mass. – Neurointerventional radiologists at UMass Memorial Medical Center (UMass Memorial), named a top 100 US hospital by national organizations, have become the first physicians in New England to use a newly approved FDA device to treat aneurysms. Ajit Puri, MD, DM, and Francesco Massari, MD, PhD, successfully used the device last week to treat a patient with an aneurysm rupture and consequent intracranial bleeding. The Comaneci device acts as a temporary bridge used to aid in the coiling processes while minimizing the risk of coil protrusion or prolapse. Once the coiling procedure is completed the device is removed from the parent artery. The device has been successfully used in about 3,000 procedures outside the US.
“Obviously we are proud to have piloted use of this device in New England but we are even more excited about its potential to help in the delivery of care to our patients and to strengthen our world class treatment center at UMass Memorial,” said Drs. Puri and Massari.
UMass Memorial Health Care
UMass Memorial Health Care is the largest not-for-profit health care system in Central Massachusetts with more than 13,000 employees and 1,700 physicians, many of whom are members of UMass Memorial Medical Group. Our member hospitals and entities include UMass Memorial HealthAlliance-Clinton Hospital, UMass Memorial – Marlborough Hospital, UMass Memorial Medical Center and UMass Memorial – Community Healthlink, our behavioral health agency. With our teaching and research partner, the University of Massachusetts Medical School, our extensive primary care network and our cancer, diabetes, heart and vascular, orthopedic and surgery programs, UMass Memorial delivers safe, high-quality and compassionate care. Visitwww.umassmemorialhealthcare.org.